期刊文献+

外周血中性粒细胞淋巴细胞比值、血小板淋巴细胞比值、CEA和AFP在原发性肝癌辅助诊断中的临床价值 被引量:8

Clinical value of the peripheral blood neutrophilic to lymphocyte ratio,platelet to lymphocyte ratio,CEA and AFP in the auxiliary diagnosis of primary liver cancer
下载PDF
导出
摘要 目的:探讨中性粒细胞淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)、血小板淋巴细胞比值(platelet to lymphpcyte ratio,PLR)、癌胚抗原(carcinoembryonic antigen,CEA)和甲胎蛋白(alpha fetal protein,AFP)单独与联合检测在原发性肝癌辅助诊断中的临床应用价值。方法:对95例肝癌病人、90例肝硬化病人及同期100名健康体检者进行血常规、血清CEA和AFP检测,并利用ROC曲线分析NLR、PLR、CEA、AFP单独和联合检测对原发性肝癌的辅助诊断价值。结果:原发性肝癌组NLR、PRL、CEA和AFP水平均高于肝硬化组和对照组,肝硬化组NLR、PRL、CEA和AFP水平也高于对照组,差异均具有统计学意义(P<0.05~P<0.01)。NLR、PRL、CEA和AFP单独及联合用于原发性肝癌辅助诊断的ROC曲线下面积分别为0.827、0.602、0.816、0.942、0.983;灵敏度分别为81.2%、67.2%、78.6%、92.5%、96.7%;特异度分别为71.3%、64.5%、73.4%、82.3%、81.2%。NLR、PRL、CEA和AFP单独及联合用于原发性肝癌鉴别诊断的ROC曲线下面积分别为0.633、0.701、0.505、0.717、0.761;灵敏度分别为61.3%、68.7%、51.2%、70.6%、78.3%;特异度分别为68.4%、72.6%、56.7%、68.7%、73.2%。结论:NLR、PLR、CEA和AFP联合诊断试验可以提高原发性肝癌辅助诊断的灵敏度,对肝硬化的鉴别诊断也具有一定临床应用价值。 Objective:To explore the clinical value of single and combined detection of neutrophil to lymphocyte ratio(NLR),platelet to lymphpcyte ratio(PLR),carcinoembryonic antigen(CEA)and alpha fetal protein(AFP)in the early diagnosis of primary hepatocellular carcinoma(HCC).Methods:The routine blood,CEA and AFP in 95 patients with primary HCC,90 cases with liver cirrhosis and 100 healthy people in the same period were detected.The clinical value of single and combined detection of NLR,PLR,CEA and AFP in the auxiliary diagnosis of primary HCC were analyzed using the receiver operating characteristic(ROC)curve.Results:The levels of NLR,PLR,CEA and AFP in primary HCC group were higher than those in cirrhosis group and control group,and the levels of NLR,PLR,CEA and AFP in cirrhosis group were also higher than those in control group(P<0.05 to P<0.01).The areas under the ROC curve,sensitivities and specificities of the single and combined detection of NLR,PLR,CEA and AFP in the auxiliary diagnosis of primary liver cancer were(0.827,0.602,0.816,0.942 and 0.983),(81.2%,67.2%,78.6%,92.5%and 96.7%)and(71.3%,64.5%,73.4%,82.3%and 81.2%),respectively.The areas under the ROC curve,sensitivities and specificities of the single and combined detection of NLR,PLR,CEA and AFP in the differential diagnosis of primary liver cancer were(0.633,0.701,0.505,0.717 and 0.761),(61.3%,68.7%,51.2%,70.6%and 78.3%)and(68.4%,72.6%,56.7%,68.7%and 73.2%),respectively.Conclusions:The combined diagnostic tests of NLR,PLR,CEA and AFP can improve the sensitivity of auxiliary diagnosis of primary HCC,and have certain clinical application value in the differential diagnosis of liver cirrhosis.
作者 郭晖 丁淑琴 郑晶 耿建 GUO Hui;DING Shu-qin;ZHENG Jing;GENG Jian(Department of Clinical Laboratory,The First Affiliated Hospital of Bengbu Medical College,Bengbu Anhui 233004;School of Laboratory Medicine,Bengbu Medical College,Bengbu Anhui 233030,China)
出处 《蚌埠医学院学报》 CAS 2022年第2期223-226,共4页 Journal of Bengbu Medical College
基金 安徽省高校自然科学研究项目(KJ2019A0323)。
关键词 原发性肝肿瘤 中性粒细胞淋巴细胞比值 血小板淋巴细胞比值 癌胚抗原 甲胎蛋白 受试者工作曲线 primary hepatocellular carcinoma neutrophil to lymphocyte ratio platelet to lymphpcyte ratio carcinoembryonic antigen alpha fetal protein receiver operating characteristic curve
  • 相关文献

参考文献4

二级参考文献38

  • 1余剑英,杨喜春.化学发光免疫法检测血清CEA,CA199和CA125水平在恶性肿瘤诊断中的意义(英文)[J].中国现代医学杂志,2004,14(16):21-23. 被引量:12
  • 2蒋显勇,罗云海.β_2-微球蛋白在原发性肝癌鉴别诊断中的临床价值的探讨[J].中国现代医学杂志,2005,15(10):1548-1549. 被引量:20
  • 3曾文,刘青光,姚英民.骨桥蛋白、甲胎蛋白表达与原发性肝癌的关系[J].中国普通外科杂志,2007,16(8):806-808. 被引量:5
  • 4中华医学会检验医学分会肿瘤标志物专家委员会.肿瘤标志物检测临床应用的基本原则(讨论稿)[J].中华检验医学杂志,2004,:27-27.
  • 5王健 吉强 殷建华 等.AFP实验室检测40年[A]..肿瘤标志专题讨论会论文集[C].,2002.27-35.
  • 6Pritzker KH. Cancer biomarkers : easier said than done. Clin Chem, 2002,48: 1147- 1150.
  • 7Fleisher M, Dnistrian AM, Sturgeon CM, et al. Practice guidelines and recommendations for use tumor markers in the clinic. Washington DC: AACC Press,2002.20-25
  • 8Lichtenstein AV, Potapova GI. Genetic defects as tumor markers. Molecular Biol, 2003,37:159-169.
  • 9Lakhani SR, Ashworth A. Microarray and histo-pathological analysis of tumours:the future and the past? Nature Rev Cancer, 2001,1:151-157.
  • 10Yu H, Diamandis EP, Levesque M, et al. Prostate specific antigen in breast cancer benign breast disease and normal breast tissue. Breast Cancer Res Treat, 1996,40:171- 178.

共引文献155

同被引文献83

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部